Evaluated antibody & sequence-to-conjugate delivery
Every lot starts with route evaluation across glycan site-specific, random, and engineered chemistries from purified antibody or sequence alone.
Coupling route evaluation: glycan, random & tailored options
| Coupling route | Mechanism & site | Selected when | Payloads supported |
|---|---|---|---|
| Glycan site-specific | Enzymatic / click coupling at Fc glycans away from Fab CDRs | CDR-sensitive antibodies needing uniform DOL & tight batch reproducibility | Small dyes, SF, pHrodo, Biotin/SA |
| Random coupling | Controlled stoichiometry via lysine NHS/TFP or thiols with SEC purification | Higher dye loading, PE/APC/tandem macromolecules, or rapid multi-panel scaling | Small dyes, SF, proteins, tandems, pHrodo, Biotin/SA |
| Other engineered routes | Partial hinge reduction, free thiols, SMCC/SPDP & Fc-less chemistry | Fab/VHH fragments, peptides/oligos, protein carriers, or custom stability targets | All small dyes, SF, proteins, tandems, pHrodo & Biotin/SA |
Sequence-to-conjugate & benchmark QC
The 6 featured benchmark CHO lots achieved ~800 mg/L titers (794.30–807.24 mg/L) and 96.24%–99.91% SEC monomer (delivered under NDA as project lots; no catalog mAbs sold).
SEC 98.21% · 4 PBMC channels
SEC 97.58% · 3 PBMC channels
Frequently asked questions
Why evaluate glycan site-specific vs. random or other routes instead of one fixed method?
Glycan site-specific suits intact IgGs requiring low, uniform DOL away from CDRs; projects needing higher payload density (proteins, tandems, multi-dye loading) or lacking Fc glycans perform better with calibrated random or engineered chemistries.
What analytical QC is delivered?
Purified conjugate, UV concentration/DOL, Waters SEC-HPLC, and SDS-PAGE; PBMC flow QC optional.
Request project evaluation
Required: project note, contact name & work email; technical fields optional.